All News

An expert explained the importance of education and involvement in care for patients with myeloproliferative neoplasms.

Reflecting on the pain I experienced before my diagnosis of multiple myeloma, I realized how important it was to pay attention to the related symptoms.

The Food and Drug Administration has approved Opdivo before and after surgery for some with non-small cell lung cancer.

The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic HER2-low or -ultralow breast cancer.

Receiving perioperative Opdivo for non-small cell lung cancer showed event-free survival benefits compared with placebo.

Among patients with HR+/HER2+ breast cancer, Herceptin and Perjeta plus endocrine therapy proved to be beneficial without chemotherapy.

Researchers are advising against the interruption of treatment with Gleevec among patients with advanced gastrointestinal stromal tumors.

After recently losing my aunt, I realized that cancer has given me a new perspective on life, which reminds me that every day has meaning.

Patients with soft tissue sarcomas showed improved functional results, quality of life and fewer side effects when treated with RT-therapy.

Keytruda continued to improve survival versus Yervoy in unresectable stage 3 or 4 melanoma in long-term follow-up data.

For patients with prostate cancer, theranostics may be another available treatment path to take, especially for those who need more options.

As a breast cancer survivor, I’ve learned to navigate the annual sea of pink, but I don’t like it.

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid cancer and breast cancer.

Fotivda monotherapy may show better outcomes in second-line therapy than the combination of Opdivo and Fotivda in metastatic kidney cancer.

Benmelstobart plus anlotinib significantly improved survival versus Sutent in the first-line treatment of advanced renal cell carcinoma.

I invited my family to gather with me and celebrate four years of being cancer-free.

The Hall of Famer has died from brain cancer at the age of 58, the NBA has announced.

In addition to increased treatment costs, patients with head and neck cancers also experienced therapy changes during the cisplatin shortage.

Patients with stage 4 non-small cell lung cancer may derive an equal benefit with a lower dose of Keytruda versus the standard dose.

Patients with HER2-positive metastatic breast cancer may consider related side effects and quality of life outcomes when choosing treatments.

Two colleagues of Amy Wallace, an oncology nurse, nominated her for the Extraordinary Healer Award based on her care of patients with lung cancer.

My path as a previvor is far from being straightforward, but having available resources and support has helped me along the way.

The approval of Retevmo is for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer.

An expert answered CURE® readers’ questions on several aspects of a prostate cancer journey, including treatment options and sexual function.

As a caregiver to my daughter who had breast cancer, pink takes on a new meaning for us — one I’m not quite a fan of.

From Ann Wilson’s return to Heart after chemotherapy to Ryan Reynolds visiting a fan with cancer, here’s what’s happening in the oncology space this week.

The FDA received an application for Nubeqa as a potential treatment option with androgen deprivation therapy for metastatic hormone-sensitive prostate cancer.

A Lynparza/cediranib combo had similar results versus standalone Lynparza among patients with relapsed platinum-sensitive ovarian cancer.